Yamamoto, Naoki

Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response

Saitoh, T., Fujita, N., Hayashi, T., Takahara, K., Satoh, T., Lee, H., Matsunaga, K., Kageyama, S., Omori, H., Noda, T., et al. (2009) · Proceedings of the National Academy of Sciences

interferon and immune responsesImmune Response and Inflammation

Cited by 854

Activation of the atf6, xbp1 and grp78 genes in human hepatocellular carcinoma: A possible involvement of the er stress pathway in hepatocarcinogenesis

Shuda, M., Kondoh, N., Imazeki, N., Tanaka, K., Okada, T., Mori, K., Hada, A., Arai, M., Wakatsuki, T., Matsubara, O., et al. (2003) · Journal of Hepatology

Endoplasmic Reticulum Stress and DiseaseHeat shock proteins research

Cited by 520

Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line

Yamamoto, N., Okada, M., Koyanagi, Y., Kannagi, M., & Hinuma, Y. (1982) · Science

T-cell and Retrovirus StudiesViral-associated cancers and disorders

Cited by 398

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Bril, V., Drużdż, A., Grosskreutz, J., Habib, A. A., Mantegazza, R., Sacconi, S., Utsugisawa, K., Vissing, J., Vu, T., Boehnlein, M., et al. (2023) · The Lancet Neurology

Myasthenia Gravis and ThymomaPeripheral Neuropathies and Disorders

Cited by 295

Increased HTLV‐I proviral DNA in HTLV‐I–associated myelopathy: A quantitative polymerase chain reaction study

Kira, J., Koyanagi, Y., Yamada, T., Itoyama, Y., Goto, I., Yamamoto, N., Sasaki, H., & Sakaki, Y. (1991) · Annals of Neurology

T-cell and Retrovirus StudiesInfectious Diseases and Tuberculosis

Cited by 152

SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype

Yamamoto, N., Ariumi, Y., Nishida, N., Yamamoto, R., Bauer, G., Gojobori, T., Shimotohno, K., & Mizokami, M. (2020) · Gene

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 141

Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas

Tanaka, K., Kondoh, N., Shuda, M., Matsubara, O., Imazeki, N., Ryo, A., Wakatsuki, T., Hada, A., Goseki, N., Igari, T., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Hepatocellular Carcinoma Treatment and PrognosisLiver physiology and pathology

Cited by 47